Why the study?
Poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease in China.
What factors influence cardioprotective medication adherence and what interventions improve it among patients with coronary heart disease in China?
Design
Systematic review
Authors
Loading...
Poor adherence in Chinese CHD patients stems from knowledge gaps and weak follow-up; leaves open need for targeted, scalable interventions in future trials.
What factors influence cardioprotective medication adherence and what interventions improve it among patients with coronary heart disease in China?
Poor cardioprotective medication adherence in Chinese CHD patients is driven by patient and physician factors, but can be improved with targeted educational and follow-up interventions.
Ni et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: